ImClone Investigational Site — Seattle, Washington

ImClone Investigational Site is a clinical research site located in Seattle, Washington, United States 98109.

Crixeo Health Trust Score: 71/100 (FAIR). This profile has not yet been claimed by the site owner.

ImClone Investigational Site has participated in 16 clinical trials.

Therapeutic areas: Sarcoma, Soft Tissue, Gastric Cancer, Metastatic Renal Cell Carcinoma.

Sponsors: Eli Lilly and Company.

Sponsor Feasibility Report

Trust Score: 71/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for ImClone Investigational Site?

ImClone Investigational Site has a Crixeo Trust Score of 71/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has ImClone Investigational Site conducted?

ImClone Investigational Site has 16 clinical trials on record. Their work covers Sarcoma, Soft Tissue, Gastric Cancer, Metastatic Renal Cell Carcinoma.

Is ImClone Investigational Site accredited by Crixeo Health?

Yes — ImClone Investigational Site holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about ImClone Investigational Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.